ClinicalTrials.Veeva

Menu

Study of Human Adipose Tissue (LOSHAT)

K

Karolinska University Hospital

Status

Unknown

Conditions

Weight Loss
Weight Gain
Lipolysis
Type 2 Diabetes Mellitus
Obesity
Human
Adipose Tissue
Weight Change, Body

Study type

Observational

Funder types

Other

Identifiers

NCT03675464
2018/809-31

Details and patient eligibility

About

The investigators will study the influence of initial fat cell size/number and adipose function (in particular lipolysis) on weight development over very long time periods (years). By comparing investigations of fat biopsies or blood samples obtained at baseline, the investigators will determine the association between adipose morphology/function and changes in weight or development of metabolic complications (e.g. metabolic syndrome, glucose intolerance, type 2 diabetes, dyslipidemia and hypertension).

Full description

The investigators will ask all subjects that have previously been examined at the investigators laboratory (from 1992 and forward) in studies of adipose tissue function if they are interested to participate in a new study.

Previously obtained results from examinations of adipose tissue, anthropometric measurements and blood samples will be used as baseline. In addition, saved blood samples and samples from old fat biopsies can be re-investigated in some cases.

The new investigation includes a questionnaire that the subjects can answer by mail or email. In addition, anthropometric measurements and blood pressure determination will be performed at a primary health care center and blood samples will be collected for analysis of fasting glucose, HbA1C and lipids.

Information regarding all previously investigated subjects will also be collected from several Swedish national patient registries such as the Patient Register, Prescribed Drug register and Cause-of Death register.

Enrollment

1,500 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Previously participated in examinations at the investigators laboratory and donated adipose tissue.
  • Previously participated in examinations at the investigators laboratory and donated blood samples that can be used to estimate lipolysis with a formula.

Exclusion criteria

  • Decline to participate after invitation.
  • Severe Psychiatric disease.
  • Type 1 Diabetes
  • Participants that have undergone bariatric surgery will be exluded in the primary analysis but will be analyzed separately in a secondary analysis for all above mentioned outcomes.

Trial contacts and locations

1

Loading...

Central trial contact

Daniel P Andersson, MD, PhD; Peter Arner, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems